Skip to content

Posts tagged ‘HER2-Positive’

0April 6, 2013Biomarker Analysis Identified Women Most Likely to Benefit From T-DM1

2December 8, 2011Addition of Trastuzumab May Potentially Equalize Disease-Free Survival Outcomes Among Obese and Normal-Weight Patients

0December 7, 2011Addition of Bevacizumab to Conventional Therapy Improved Progression-Free Survival in HER2-Positive Breast Cancer

0December 7, 2011Dual HER2 Blockade Significantly Extends Progression-Free Survival

0December 10, 2010Combination Therapy Reduced HER2-positive Breast Cancers

0December 30, 2009SABCS 2009 Interview with Kimberly L. Blackwell, M.D

Categories
Categories
AACR on Twitter:
- Today, the @US_FDA granted accelerated approval to pirtobrutinib, a targeted therapy for adult patients with relaps… twitter.com/i/web/status/1… 4 hours ago
- Today the @US_FDA approved the targeted therapeutic elacestrant to treat certain postmenopausal women or adult men… twitter.com/i/web/status/1… 6 hours ago
- While the past decade has brought progress against cervical cancer, challenges remain, especially for older women a… twitter.com/i/web/status/1… 8 hours ago
- Register by February 1 to get the lowest rates for the AACR Special Conference on Advances in Prostate Cancer Resea… twitter.com/i/web/status/1… 9 hours ago
- Deborah Schrag, David @DeNardoLabWUSM, @tomi_akinyemiju, Robert Yarchoan, and @TeresaZimmers will present their cut… twitter.com/i/web/status/1… 11 hours ago
AACR Journal RSS Feeds
AACR News Feeds
- AACR News
- AACR Scientific Podcasts
Follow the AACR Online